Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Groupe Sebbin manufactures and markets a range of silicone-based implantable medical devices used in cosmetic and reconstructive surgeries. The company has launched large-scale prospective clinical trials to evaluate the long-term safety of its silicone breast implants. Its latest product line includes nano-textured breast implants ("Integrity"), with ongoing clinical evaluation for gluteal implants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Groupe Sebbin.